Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (221-230 of 534) with videos related to

Pageof 54
Sort By:
The Journal of Infectious Diseases|March 29, 2002
Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infectionGalit Alter, Alefia Merchant, Christos M Tsoukas, et al.
NPJ Vaccines|December 3, 2022
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in childrenYannic C Bartsch, Jessica W Chen, Jaewon Kang, et al.
Frontiers in Microbiology|May 25, 2023
Maternal HIV infection drives altered placental <i>Mtb</i>-specific antibody transferNadege Nziza, Wonyeong Jung, Maanasa Mendu, et al.
The Journal of Clinical Investigation|August 26, 2021
The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in childrenRebecca A Porritt, Aleksandra Binek, Lisa Paschold, et al.
Mbio|March 10, 2021
Viral Rebound Kinetics Correlate with Distinct HIV Antibody FeaturesYannic C Bartsch, Carolin Loos, Evan Rossignol, et al.
The Journal of Infectious Diseases|March 24, 2022
Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 VaccineJenny S Maron, Michelle Conroy, Vivek Naranbai, et al.
Journal of Immunological Methods|January 4, 2011
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesMargaret E Ackerman, Brian Moldt, Richard T Wyatt, et al.
NPJ Vaccines|January 5, 2024
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spikeWonyeong Jung, Dansu Yuan, Benjamin Kellman, et al.
Nature Immunology|December 1, 2022
The persistence of memory: defining, engineering, and measuring vaccine durabilityAmy C Palin, Galit Alter, Shane Crotty, et al.
JCI Insight|February 23, 2026
SARS-CoV-2 antibody-dependent enhancement of infection depends on antibody binding to both ACE2 and Fc receptorsNatalia A Kuzmina, Sivakumar Periasamy, Kritika Kedarinath, et al.
Pageof 54

Showing results (221-230 of 534) with videos related to

Sort By:
Pageof 54
The Journal of Infectious Diseases|March 29, 2002
Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infectionGalit Alter, Alefia Merchant, Christos M Tsoukas, et al.
NPJ Vaccines|December 3, 2022
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in childrenYannic C Bartsch, Jessica W Chen, Jaewon Kang, et al.
Frontiers in Microbiology|May 25, 2023
Maternal HIV infection drives altered placental <i>Mtb</i>-specific antibody transferNadege Nziza, Wonyeong Jung, Maanasa Mendu, et al.
The Journal of Clinical Investigation|August 26, 2021
The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in childrenRebecca A Porritt, Aleksandra Binek, Lisa Paschold, et al.
Mbio|March 10, 2021
Viral Rebound Kinetics Correlate with Distinct HIV Antibody FeaturesYannic C Bartsch, Carolin Loos, Evan Rossignol, et al.
The Journal of Infectious Diseases|March 24, 2022
Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 VaccineJenny S Maron, Michelle Conroy, Vivek Naranbai, et al.
Journal of Immunological Methods|January 4, 2011
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesMargaret E Ackerman, Brian Moldt, Richard T Wyatt, et al.
NPJ Vaccines|January 5, 2024
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spikeWonyeong Jung, Dansu Yuan, Benjamin Kellman, et al.
Nature Immunology|December 1, 2022
The persistence of memory: defining, engineering, and measuring vaccine durabilityAmy C Palin, Galit Alter, Shane Crotty, et al.
JCI Insight|February 23, 2026
SARS-CoV-2 antibody-dependent enhancement of infection depends on antibody binding to both ACE2 and Fc receptorsNatalia A Kuzmina, Sivakumar Periasamy, Kritika Kedarinath, et al.
Pageof 54